Trial intelligence / Profile preview

Analgesic efficacy of wound infiltration vs TAP block in laparoscopic colorectal surgery

2023-507090-18-00Phase 4Authorised

Sponsor
Hospital Universitario La Paz
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of levobupivacaine in postoperative pain (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoint: Total opioid consumption at 48 hours after surgery. Planned start Oct 2023; status: authorised.

02

Drugs

levobupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2023-507090-18-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2023-507090-18-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call